Added by Diane schaller on December 29, 2014 at 10:35pm — No Comments
Our friends in Spain are looking for help in supporting the biggest and most important research team in Spain, which ASHUA has collaborated with for a long time. In this particular project, the researcher Dr. Santiago Rodriguez de Cordoba, would like to create a database about all the patients screened by them, and from that, try to identify how to customize the aHUS treatment for every patient. To learn more about the research effort and how you can help go to the following link. (To…Continue
Added by Jeff Schmidt on December 29, 2014 at 7:58am — No Comments
When you read about a new drug under study, there are several steps before a drug makes it to market. So what does it all mean?
While guidelines may be similar in other countries, this information is adapted from two US government websites, and pertains specifically to trials registered in the US. For more information see:Continue
One of our members has asked what effect the level of targeted complement inhibition (upstream/early or downstream/late in the cascade) has on the risk of infection. As several new complement inhibitors are under development, most targeting a different component than C5 targeted by Soliris®, this is a practical concern moving forward. I think the relative risks and benefits of alternative drug targets is a fascinating question, and one that has been on my mind as well, and unfortunately one…Continue
Added by Grace on December 24, 2014 at 9:00pm — No Comments
If you can't find it, search Frozen Parody I Don't Know.
It's how I felt when the doctors didn't have a clue about what I had.
Added by Lisa Stockdale on December 23, 2014 at 9:35pm — No Comments
Shouldn’t I really be doing something more productive this busy time of year? Probably - but in a sunny nook of our home, my 10 year old son and I are working on a 1000 piece jigsaw puzzle. It’s a fun and relaxing way to use those tiny odd bits of time ‘in between’ life’s activities and obligations. It suddenly struck me while pondering those tiny pieces: Working on a jigsaw puzzle is a lot like trying to sort out life’s issues.
We usually have a pretty…Continue
As difficult as it has been at times, the world of aHUS has also brought us new friendships. In these last two weeks as we continue to support each other in reaching our $10k goal for the aHUS Foundation (that will be matched dollar for dollar), We offer you the opportunity to purchase a t-shirt designed by our…Continue
Check out the following link to see the faces and stories of some of our Australian friends. Things have changed for some of them as Soliris is now available as of Dec. 1 to those their government says are in urgent need. Others are still waiting and need to relapse to receive Soliris. Take a moment to get to know these aHUS warriers.
First off, my name is Megan, I am a college student, a dedicated worker, a sister, a daughter, a friend, and LASTLY a patient. I do not let aHUS define me and while I acknowledge that I have it and have limitations, I also don't let it control my life. I was diagnosed the summer of my sophomore year in college, and just finished my fall semester of my junior year. I typically take 18 credits, although this semester I only took 15. However I also have three jobs on top of my frequent doctors…Continue
As I mentioned last week our Canadian friends are still waiting for their government to provide access to Soliris (except in Quebec where their government has approved it). aHUS Canada has an awesome email tool to make it easy for anyone to send emails to the various Premiers and Health Ministers. I encourage everyone to help our Canadian friends by using the email tool. It's easy as they have provided a template you can use. But what will make the email more impactful is if you add…
Added by Jeff Schmidt on December 10, 2014 at 9:01pm — No Comments
The global aHUS Alliance today announced that September 24, 2015 has been declared as the first annual International aHUS Awareness Day. World Rare Disease Day is marked each year on the last day of February, when the media spotlight can lend awareness to an estimated 7000 rare diseases and on those challenged by those diagnoses. Patient organizations in the UK, America, Spain, France, Canada and other nations have joined together in…Continue
Added by Linda Burke on December 4, 2014 at 9:00am — No Comments
Lisa and Linda recently brought two new drugs to my attention, and much of the following information is cross-posted from the "Potential New Treatments" forum.
TNT009 is a humanized antibody which inhibits C1s, one of a series of proteins which bind to antibody-antigen complexes and activate the classical pathway of complement, under development…Continue
This is news AHUSUK has been waiting for. On November 27, 2014, the National Institute for Health and Care Excellence (NICE) made public its Final Evaluation Determination (FED) for eculizumab (Soliris) for aHUS. Congratulations to all of our friends in the UK. This has been a long time coming! Check the link for details.
Added by Cheryl Biermann on December 2, 2014 at 11:07am — No Comments
The Las Vegas aHUS Meetup is coming up this weekend, and those attending will hear great presentations by Dr. Rita Swinford (aHUS medical update), Dr Maya Doyle (navigating challenges), and Barb Farcher (representing The Atypical HUS Foundation). Global Genes is hosting this last aHUS regional meeting of 2014, and we hope to hear announcements soon from both NORD and Global Genes concerning aHUS regional meeting locations and dates for 2015. What a terrific support these 2014…Continue
Added by Linda Burke on December 1, 2014 at 7:30pm — No Comments